SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$561M
AUM Growth
-$168M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$91.9M
2
+$9.53M
3
+$2.81M
4
SEPN
Septerna Inc
SEPN
+$2.2M

Top Sells

1
+$12.5M
2
+$11.8M
3
+$7.76M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$5.91M
5
CLYM
Climb Bio
CLYM
+$4.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRK icon
1
Scholar Rock
SRRK
$2.69B
$180M 32.18%
5,612,896
KLRS
2
Kalaris Therapeutics
KLRS
$86.6M
$91.9M 16.39%
11,448,081
+11,444,501
MLYS icon
3
Mineralys Therapeutics
MLYS
$3.38B
$90.1M 16.07%
5,674,916
+600,000
NGNE icon
4
Neurogene
NGNE
$414M
$20.1M 3.59%
1,717,127
ALMS
5
Alumis Inc
ALMS
$467M
$20.1M 3.58%
3,266,498
PVLA
6
Palvella Therapeutics
PVLA
$809M
$19M 3.39%
679,486
SEPN
7
Septerna Inc
SEPN
$984M
$18.2M 3.25%
3,149,128
+380,608
CRGX
8
DELISTED
CARGO Therapeutics
CRGX
$18M 3.2%
4,415,689
LENZ
9
LENZ Therapeutics
LENZ
$1.16B
$13.5M 2.41%
526,390
-460,591
UPB
10
Upstream Bio Inc
UPB
$1.13B
$12.7M 2.26%
2,067,146
-150,000
ACLX icon
11
Arcellx
ACLX
$4.82B
$8.87M 1.58%
135,276
-118,365
ZYME icon
12
Zymeworks
ZYME
$1.39B
$7.94M 1.42%
666,667
-333,333
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.48B
$7.58M 1.35%
967,527
RYTM icon
14
Rhythm Pharmaceuticals
RYTM
$7.32B
$7.32M 1.3%
138,118
-34,529
NKTX icon
15
Nkarta
NKTX
$163M
$6.93M 1.24%
3,768,035
GOSS icon
16
Gossamer Bio
GOSS
$501M
$6.74M 1.2%
6,130,268
SLRN
17
DELISTED
ACELYRIN
SLRN
$6.23M 1.11%
2,523,022
CTNM
18
Contineum Therapeutics
CTNM
$328M
$4.11M 0.73%
588,816
VTVT icon
19
vTv Therapeutics
VTVT
$52.9M
$3.58M 0.64%
206,784
OKUR
20
OnKure Therapeutics
OKUR
$37.6M
$3.54M 0.63%
824,155
SRZN icon
21
Surrozen
SRZN
$116M
$2.81M 0.5%
+241,400
ABVX
22
Abivax
ABVX
$7.22B
$2.66M 0.47%
425,000
-425,000
STRO icon
23
Sutro Biopharma
STRO
$85.6M
$1.43M 0.25%
2,196,814
INZY
24
DELISTED
Inozyme Pharma
INZY
$1.42M 0.25%
1,562,500
ARTV
25
Artiva Biotherapeutics
ARTV
$147M
$875K 0.16%
291,666
1
2